Two-year results of treatment with methionyl human growth hormone in children with Turner syndrome. Dutch Growth Hormone Working Group.

C Rongen-Westerlaken, M H Fokker, J M Wit, S M De Muinck Keizer-Schrama, B J Otten, W Oostdijk, H A Delemarre van den waal, M H Gons, A Bot
Author Information
  1. C Rongen-Westerlaken: Department of Paediatrics, University of Utrecht, The Netherlands.

Abstract

Methionyl growth hormone (somatrem) in a daily dosage of 4 IU/m2 body surface area was administered to 16 girls with Turner syndrome. Low dose ethinyl estradiol (0.1 microgram/kg body weight) was added in girls aged 13 years or more. Mean (SD) height velocity increased from 3.4 (0.9) to 7.2 (1.7) and 5.3 (1.3) cm/year in the first and second year, respectively. Bone age advanced 1.8 years over 2 years and predicted adult height was increased. Apart from the occurrence of anti-GH antibodies there were no side effects. In conclusion, somatrem is an efficacious and safe therapy for short stature in Turner syndrome over a period of 2 years. Longer follow-up is needed before conclusions about its effect on final height can be drawn.

MeSH Term

Adolescent
Body Height
Child
Female
Follow-Up Studies
Growth Hormone
Hormones
Human Growth Hormone
Humans
Recombinant Proteins
Turner Syndrome

Chemicals

Hormones
Recombinant Proteins
Human Growth Hormone
Growth Hormone

Word Cloud

Created with Highcharts 10.0.01yearsTurnersyndromeheight32growthhormonesomatrem4bodygirls0increased7MethionyldailydosageIU/m2surfaceareaadministered16Lowdoseethinylestradiolmicrogram/kgweightaddedaged13MeanSDvelocity95cm/yearfirstsecondyearrespectivelyBoneageadvanced8predictedadultApartoccurrenceanti-GHantibodiessideeffectsconclusionefficacioussafetherapyshortstatureperiodLongerfollow-upneededconclusionseffectfinalcandrawnTwo-yearresultstreatmentmethionylhumanchildrenDutchGrowthHormoneWorkingGroup

Similar Articles

Cited By